An optimized Nurr1 agonist provides disease-modifying effects in Parkinson's disease models.
Kim W, Tripathi M, Kim C, Vardhineni S, Cha Y, Kandi SK, Feitosa M, Kholiya R, Sah E, Thakur A, Kim Y, Ko S, Bhatia K, Manohar S, Kong YB, Sindhu G, Kim YS, Cohen B, Rawat DS, Kim KS.
Kim W, et al. Among authors: kong yb.
Nat Commun. 2023 Jul 18;14(1):4283. doi: 10.1038/s41467-023-39970-9.
Nat Commun. 2023.
PMID: 37463889
Free PMC article.